SEC 13F Intelligence

Managers / Q2 2021 · view latest →

ISZO CAPITAL MANAGEMENT LP

CIK 0001607925 · 590 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY, 10022 · 646-775-4394

Reported Value
$275M
Q2 2021
Positions
8
Filings on Record
22
2019–present window
Filed
Aug 16, 2021
original filing

Summary

Iszo Capital Management LP reported $275M in U.S.-listed holdings across 8 positions for Q2 2021.

The portfolio is heavily concentrated: Nam Tai Ppty alone accounts for 51.6% of reported value.

Compared with Q1 2021, the fund opened 3 new positions and exited 0.

Portfolio Metrics

Turnover
+19.4%
vs prior filed quarter
Largest Position
+51.6%
Nam Tai Ppty

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $92MQ4 ’18Q1 ’19: $61MQ2 ’19: $64MQ3 ’19: $76MQ3 ’19Q4 ’19: $69MQ1 ’20: $65MQ2 ’20: $57MQ2 ’20Q3 ’20: $74MQ4 ’20: $96MQ1 ’21: $212MQ1 ’21Q2 ’21: $275MQ3 ’21: $227MQ4 ’21: $190MQ4 ’21Q1 ’22: $84MQ2 ’22: $64MQ3 ’22: $58MQ3 ’22Q4 ’22: $7MQ1 ’23: $19MQ2 ’23: $18MQ2 ’23Q3 ’23: $2MQ4 ’23: $2Mfilingsflow.com

Portfolio Composition

By security type
Other: 51.6%Common Stock: 48.4%
  • Other · 51.6% · $142M
  • Common Stock · 48.4% · $133M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ATEXANTERIX INCNEW+126.3K126.3K+$8M$8M
PTGXPROTAGONIST THERAPEUTICS INCNEW+93.9K93.9K+$4M$4M
CHICOS FAS INCNEW+20.7K20.7K+$136,000$136,000
DMTKQDERMTECH INCTRIMMED−732.1K1.09M−$47M$45M
NOTVQINOTIV INCTRIMMED−46.6K266.9K+$850,000$7M
NAM TAI PPTY INCHELD−155.8K5.13M+$77M$142M
AVID BIOSERVICES INCHELD+02.35M+$17M$60M
XPELXPEL INCHELD+0103.9K+$3M$9M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2021

8 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NAM TAI PPTY INCSHS51.61%$142M5.13M
2AVID BIOSERVICES INCCOM21.86%$60M2.35M
3DMTKQDERMTECH INChistory →COM16.46%$45M1.09M
4XPELXPEL INChistory →COM3.16%$9M103.9K
5ATEXANTERIX INChistory →COM2.75%$8M126.3K
6NOTVQINOTIV INChistory →COM2.59%$7M266.9K
7PTGXPROTAGONIST THERAPEUTICS INChistory →COM1.53%$4M93.9K
8CHICOS FAS INCCOM0.05%$136,00020.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2023$2M1Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$2M3Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$18M3Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$19M10May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$7M7Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$58M6Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$64M6Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$84M5May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$190M7Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$227M7Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$275M8Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$212M5May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$96M6Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$74M5Nov 17, 2020RESTATEMENTchanges · EDGAR ↗
Q2 2020$57M10Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$65M10May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$69M3Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$76M4Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$64M2Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$61M5May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$92M5Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.